Company Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally.
Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories.
The company also rents its products directly to patients.
Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
| Country | United States |
| IPO Date | Feb 14, 2014 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 834 |
| CEO | Kevin R. M. Smith |
Contact Details
Address: 301 Coromar Drive Goleta, California United States | |
| Website | https://www.inogen.com |
Stock Details
| Ticker Symbol | INGN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001294133 |
| CUSIP Number | 45780L104 |
| ISIN Number | US45780L1044 |
| Employer ID | 00-0000000 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Kevin R. M. Smith | President, Chief Executive Officer & Director |
| Michael J. Bourque CPA | Executive Vice President, Chief Financial Officer & Treasurer |
| Adrien Mithalal | Senior Vice President of Research & Development |
| Dr. Krishna Jhaveri | Chief Medical Officer |
| Grgoire Ramade | Executive Vice President & Chief Commercial Officer |
| Jennifer Yi Boyer | Executive Vice President & Chief Human Resources Officer |
| Kevin P. Smith | General Counsel & Executive Vice President of Business Development |
| Paul Andreassi | Senior Vice President of Quality & Regulatory Affairs |
| Philip Corrin | Senior Vice President of Operations & Supply Chain |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 03, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Dec 03, 2024 | 3/A | [Amend] Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 08, 2024 | 10-Q | Quarterly Report |
| Nov 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 07, 2024 | 8-K | Current Report |
| Oct 22, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 07, 2024 | 10-Q | Quarterly Report |
| Aug 06, 2024 | 8-K | Current Report |